clinical trial · NCT07419828
A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease
Shandong Suncadia Medicine Co., Ltd.·phase3·recruiting·n = 1,978
Chronic Kidney DiseaseHRS-1780 tabletsPlacebo
brief summary
The study is a Phase III clinical trial to evaluate the superiority of HRS-1780 tablets compared with placebo in delaying renal function decline in participants with chronic kidney disease (CKD) on the basis of standard treatment.
started
Mar 13, 2026
primary completion
Apr 1, 2030
completion
May 1, 2030
last updated
Mar 27, 2026
official title
A Multicenter, Randomized, Double-blind, Placebo- Controlled Phase III Study Evaluating the Efficacy and Safety of HRS-1780 in Adult Participants With Chronic Kidney Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol